How to Choose the Right Treatment for Your Patient

In the last year, I had an aha moment and some of it was based on data. It was Philip Harder's subanalysis on a high risk versus low risk group of patients from Apollo 1. And they found that when you look at this low risk group patients, now remembering low risk advanced ovarian cancer, I'm not sure there exists a low riskAdvanced ovarian cancer patients. 85% plus or minus 5% of low risk are still going to recur. The same as high risk. So for me, with my intent to increase the opportunity for curative intent for our patients, that aha moment was, I'm going to have the best therapies available to my patient at